It looks like your browser is not up to date.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

ElectroCore Inc (ECOR) USD0.001

Sell:$1.60 Buy:$1.62 Change: $0.07 (4.52%)
Market closed |  Prices as at close on 18 May 2021 | Switch to live prices |
Sell:$1.60
Buy:$1.62
Change: $0.07 (4.52%)
Market closed |  Prices as at close on 18 May 2021 | Switch to live prices |
Sell:$1.60
Buy:$1.62
Change: $0.07 (4.52%)
Market closed |  Prices as at close on 18 May 2021 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

ElectroCore, Inc., formerly ElectroCore LLC, is a commercial-stage bioelectronic medicine healthcare company. The Company is engaged in developing non-invasive vagus nerve stimulation (nVNS) therapy for the treatment of multiple conditions in neurology, psychiatry, gastroenterology and respiratory fields. The Company's gammaCore is a simple-to-use hand-held device that provides non-invasive dispensing therapy, which stimulates the cervical branch of the vagus nerve. The gammaCore is a non-drug treatment for adults who suffer from episodic cluster and migraine pain. The Company's target is the treatment of primary headaches (migraine and cluster headache), and the associated chronic co-morbidities of gastric motility, psychiatric, sleep and pain disorders.

Contact details

Address:
200 FORGE WAY, SUITE 205
ROCKAWAY
07866
United States
Telephone:
+1 (973) 2900097
Website:
https://www.electrocore.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
ECOR
ISIN:
US28531P1030
Market cap:
$77.19 million
Shares in issue:
48.54 million
Sector:
Health Care Equipment
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • Michael Atieh
    Independent Chairman of the Board
  • Daniel Goldberger
    Chief Executive Officer, Director
  • Brian Posner
    Chief Financial Officer
  • Mike Romaniw
    Executive Vice President - Systems & Operations
  • Eric Liebler
    Senior Vice President - Neurology
  • Sylvester Steele
    Vice President, General Manager of the Government Channels Business Unit

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.